ARETEIA THERAPEUTICS
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.
ARETEIA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2022-01-01
Address:
Bernardsville, New Jersey, United States
Country:
United States
Website Url:
http://www.areteiatx.com
Total Employee:
11+
Status:
Active
Total Funding:
425 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Laravel Livewire
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Calman Prussin Senior Vice President, Chief Scientific Officer @ Areteia Therapeutics
Senior Vice President, Chief Scientific Officer
2022-07-01
Robin Walker Chief Legal Officer and Corporate Secretary @ Areteia Therapeutics
Chief Legal Officer and Corporate Secretary
2022-09-01
Mark Kreston SVP & Chief Commercial Officer @ Areteia Therapeutics
SVP & Chief Commercial Officer
2022-07-01
Jorge Bartolome Co-Founder and Chief Executive Officer @ Areteia Therapeutics
Co-Founder and Chief Executive Officer
2022-07-01
Eric Bradford Chief Medical Officer @ Areteia Therapeutics
Chief Medical Officer
2022-10-01
Christopher Courts Co-Founder and Chief Financial Officer @ Areteia Therapeutics
Co-Founder and Chief Financial Officer
2022-11-01
Founder
Investors List
Marshall Wace
Marshall Wace investment in Series A - Areteia Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Areteia Therapeutics
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series A - Areteia Therapeutics
Maverick Capital
Maverick Capital investment in Series A - Areteia Therapeutics
Google Ventures
Google Ventures investment in Series A - Areteia Therapeutics
Viking Global Investors
Viking Global Investors investment in Series A - Areteia Therapeutics
Access Biotechnology
Access Biotechnology investment in Series A - Areteia Therapeutics
Sanofi
Sanofi investment in Series A - Areteia Therapeutics
Population Health Partners
Population Health Partners investment in Series A - Areteia Therapeutics
Saturn Partners
Saturn Partners investment in Series A - Areteia Therapeutics
Key Employee Changes
Official Site Inspections
http://www.areteiatx.com Semrush global rank: 6.27 M Semrush visits lastest month: 1.06 K
- Host name: 172.67.74.91
- IP address: 172.67.74.91
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Areteia Therapeutics"
Areteia Therapeutics - Bain Capital Life Sciences
Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing the first …See details»
Knopp Biosciences and Population Health Partners Create Areteia ...
Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing the first …See details»
Areteia Therapeutics - Crunchbase Company Profile
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.See details»
AreteiaTx - LinkedIn
AreteiaTx | 1,463 followers on LinkedIn. Pioneering a new era in asthma control | Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of ...See details»
Areteia Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Areteia Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
AreteiaTx - Leadership Team | The Org
The Leadership Team at Areteia Therapeutics is responsible for steering the company's strategic direction, overseeing drug development and clinical research, ensuring financial health, and …See details»
Areteia Therapeutics to Present at the 42nd Annual J.P. Morgan ...
Jan 3, 2024 Areteia (areteiatx.com) is a clinical stage biotechnology company whose purpose is to develop and deliver novel Inflammation and Immunology (I&I) therapies that put respiratory …See details»
Ian Read named Chairman of the Board of Areteia Therapeutics
Sep 7, 2022 Areteia Therapeutics, Inc. (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing …See details»
Areteia Therapeutics Granted ILAP Designation from UK MHRA for …
Feb 23, 2023 Areteia Therapeutics ( areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing …See details»
Areteia Therapeutics Announces Additional $75MM in Series A …
Feb 13, 2024 Areteia Therapeutics, Inc. (areteiatx.com) is a clinical stage biotechnology company whose purpose is to develop and deliver novel Inflammation and Immunology …See details»
Areteia Therapeutics - Craft
Areteia Therapeutics has 5 employees at their 1 location and $350 m in total funding,. See insights on Areteia Therapeutics including office locations, competitors, revenue, financials, …See details»
Areteia Therapeutics Announces Start of Phase III Clinical Trials of ...
Mar 9, 2023 Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing …See details»
Bain Capital
Jul 12, 2022 Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing …See details»
Areteia Therapeutics announces the appointments of Dr. Eric …
Oct 5, 2022 Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing …See details»
Areteia Therapeutics Announces Start of Phase III Clinical Trials of ...
Mar 9, 2023 Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing …See details»
Areteia Therapeutics Announces Publication of Phase II Data of …
Aug 3, 2023 Areteia Therapeutics, Inc. (areteiatx.com) is a clinical stage biotechnology company whose purpose is to develop and deliver novel Inflammation and Immunology (I&I) therapies …See details»
Areteia Therapeutics announces the appointment of Christopher …
Nov 9, 2022 Areteia Therapeutics (areteiatx.com) is a clinical stage biotechnology company committed to putting asthma patients in better control of their disease and lives by developing …See details»
Areteia Therapeutics to Present at the 42 - Business Wire
Jan 3, 2024 Areteia Therapeutics, Inc. ( areteiatx.com) is a clinical stage biotechnology company whose purpose is to develop and deliver novel Inflammation and Immunology therapies that …See details»
Areteia Therapeutics Announces - Business Wire
Aug 3, 2023 Areteia Therapeutics, Inc. (areteiatx.com) is a clinical stage biotechnology company whose purpose is to develop and deliver novel Inflammation and Immunology (I&I) therapies …See details»